期刊文献+

程序性死亡因子配体1在脂肪间充质干细胞抑制大鼠肝移植术后排斥反应中的作用

The role of programmed death ligand 1 in adipose-derived mesenchymal stem cells-induced inhibition of rejection following liver transplantation and possible mechanisms
原文传递
导出
摘要 目的 探讨脂肪间充质干细胞(ADMSCs)对大鼠肝移植术后排斥反应的影响及其机制.方法 分离培养SD大鼠ADMSCs,构建RNA干扰慢病毒载体转染ADMSCs阻断程序性死亡因子配体1(PD-L1).以SD为供体、Wistar大鼠为受体建立肝移植模型,随机分为A(空白组)、B(对照组)、C(实验组)3组,分别以生理盐水2 ml/ADMSCs(1×107个)/慢病毒转染后ADMSCs(1×10 7个)处理,比较3组大鼠肝移植术后7d肝功能、白细胞介素(IL)-2和IL-10、肝脏病理改变及干细胞凋亡、肝脏组织B细胞淋巴瘤/白血病-2(bcl-2)和bcl相关X蛋白(bax)表达差异.结果 A组血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆红素(TBIL)、IL-2和IL-10水平分别为(188.9±30.8)U/L、(177.1 ±27.9) U/L、(53.8±14.1)μmol/L、(296.32±56.25) ng/L、(74.92±10.98) ng/L;B组为(114.2±22.7) U/L、(134.8±18.1) U/L、(27.7±5.2)μmol/L、(186.36±17.84) ng/L、(194.56±36.87) ng/L;C组为(160.5 ±28.3) U/L、(155.6±25.6) U/L、(41.2±10.3) μmol/L、(250.95±42.68) ng/L、(125.52 ±26.34) ng/L,3组间差异有统计学意义(P<0.05).原位缺口末端标记法(TUNEL)检测A、B、C组的凋亡指数分别为35.86 ±5.92、12.39±2.23和28.47 ±4.32,3组间差异有统计学意义(P<0.05).B组大鼠肝移植模型术后bcl-2表达显著高于A组和C组,C组bcl-2表达低于A组;A组bax表达高于A组和C组,C组bax表达高于A组.结论 ADMSCs可显著降低肝移植术后排斥反应,PD-L1通路可能在其抑制排除反应中起重要作用. Objective The present study was designed to investigate the role of Adipose-derived mesenchymal stem cells (ADMSCs) in hver transplantation and possible mechanisms.Methods Thirty six rats (A,B and C groups) were infused normal saline,ADMSCs,or programmed death ligand 1 (PD-L1)-knockdown ADMSCs,then received orthotopic liver transplantation.Seven days following transplantation,liver function,cytokines,and apoptosis were examined.Results Liver function results showed that the levels of alanine transaminase (ALT),aspartate aminotransferase (AST),total bilirubin (TBIL),interleukin (IL)-2 and IL-10 for those groups were:(188.9 ±30.8) U/L,(177.1 ±27.9) U/L,(53.8 ± 14.1) μmol/L,(296.32 ± 56.25) ng/L,(74.92 ± 10.98) ng/L; (114.2 ± 22.7) U/L,(134.8 ± 18.1) U/L,(27.7±5.2) μmol/L,(186.36 ±17.84) ng/L,(194.56 ±36.87) ng/L; (160.5 ± 28.3) U/L,(155.6±25.6) U/L,(41.2±10.3) μmol/L,(250.95±42.68) ng/L,(125.52 ± 26.34) ng/L.ADMSCs infusion significantly suppressed liver cell apoptosis,increased bcl-2 level,and decreased bax level.These apoptosis-related changes were reduced by PD-L1 knockdown.Conclusion Together these,our results demonstrated the protective role of ADMSCs in liver transplantation rejection,and suggest that PD-L1 underlie the mechanism.
作者 张宇 万赤丹
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2014年第8期1731-1734,F0003,共5页 Chinese Journal of Experimental Surgery
关键词 脂肪间充质干细胞 肝移植术 排斥反应 程序性死亡因子配体1 Adipose-derived mesenchymal stem cells Liver transplantation Rejection Programmed death ligand 1
  • 相关文献

参考文献21

  • 1Bassi (E)J,Moraes-Vieira PM.Immune regulatory properties of allogeneic adipose-derived mesenchymal stem cells in the treatment of experimental autoimmune diabetes[J].Diabetes,2012,61 (10):2534-2545.
  • 2Lee JH,Jeon EJ.The synergistic immunoregulatory effects of cultureexpanded mesenchymal stromal cells and CD4 (+) 25 (+) Foxp3 + regulatory T cells on skin allograft rejection[J].PLoS One,2013,8 (8):e70968.
  • 3Saha A,Aoyama K.Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality[J].Blood,2013,122 (17):3062-3073.
  • 4Kamada N,Calne RY.Orthotopic liver transplantation in the rat.Technique using cuff for portal vein anastomosis and biliary drainage[J].Transplantation,1979,28 (1):47-50.
  • 5李煜环,宋振顺,范子扬,张福琴.骨髓间充质干细胞体外对1型糖尿病大鼠淋巴细胞的免疫调节作用[J].中华实验外科杂志,2011,28(2):209-211. 被引量:12
  • 6Vanikar AV,Trivedi HL,Gopal SC,et al.Pre-transplant co-infusion of donor-adipose tissue derived mesenchymal stem cells and hematopoietic stem cells may help in achieving tolerance in living donor renal transplantation[J].Ren Fail,2013,36(3):457-460.
  • 7Casiraghi F,Remuzzi G,Perico N.Mesenchymal stromal cells to promote kidney transplantation tolerance[J].Curr Opin Organ Transplant,2014,19(1):47-53.
  • 8Introna M,Lucchini G,Dander E,et al.Treatment of graft versus host disease with mesenchymal stromal cells:a phase Ⅰ study on 40 adult and pediatric patients[J].Biol Blood Marrow Transplant,2013,20 (3):375-381.
  • 9Meisel R,Zibert A,Laryea M,et al.Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation[J].Blood,2004,103 (12):4619-4621.
  • 10DelaRosa O,Lombardo E,Beraza A,et al.Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells[J].Tissue Eng Part A,2009,15 (10):2795-2806.

二级参考文献21

  • 1李宾公,曾秋棠,王红祥,邹萍,王庆海.脂肪来源与骨髓来源的基质干细胞的比较[J].中华器官移植杂志,2006,27(3):142-144. 被引量:13
  • 2王轩,杨甲梅,严以群,姚晓平,吴孟超.大鼠原位肝移植模型术式的改进[J].中华实验外科杂志,1997,14(1):59-60. 被引量:22
  • 3栾希英,张光波,胡玉敏,於葛华,王明元,段巧艳,段祥,张学光.人骨髓MSC对PHA活化T细胞周期以及表型和细胞因子分泌的影响[J].细胞与分子免疫学杂志,2007,23(5):402-405. 被引量:16
  • 4Abdi R,Fiorina P,Adra CN,et al.Immunomodulation by mesenchymal stem cells:a potential therapeutic strategy for type 1 diabetes.Diabetes,2008,57:1759-1767.
  • 5Selmani Z,Naji A,Zidi I,et al.Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4 + CD25 + high-FOXP3 + regulatory T cells.Stem Cells,2008,26:212-222.
  • 6Sensebe L,Bourin P.Mesenchymal sten cells for therapeutic purposes.Transplantation,2009,87:49-53.
  • 7Tritt M,Sgouroudis E,D' Hennezel E,et al.Functional waning of naturally occurring CD4 + regulatory T-cells contributes to the onset of autoimmune diabetes.Diabetes,2008,57:113-123.
  • 8Glennie S,Soeiro I,Dyson PJ,et al.Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells.Blood,2005,105:2821-2827.
  • 9Bartholomew A,Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol,2002 ,30 :42-48.
  • 10Kamada N,Calne RY. A surgical experience with five hundred thirty liver tarnsplants in the rat. Surgery,1983,93:64-69.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部